TomoTherapy Tops MD Buyline Rankings for Second Straight Quarter
MADISON, Wis. (PRWEB / Business Wire EON) July 2, 2008 --
TomoTherapy Incorporated
(NASDAQ: TOMO), maker of the TomoTherapy®
Hi·Art®
treatment system for advanced radiation therapy, has earned top honors
in MD Buyline’s user satisfaction rankings for
the second consecutive quarter, solidifying its position as the customer
service leader in linear accelerator-based radiation therapy.
MD Buyline measures user satisfaction based on evaluations by more than
3,300 hospitals in the member network. Members rank their satisfaction
in six areas: system performance; system reliability; installation and
implementation; applications training; service response time; and
service repair quality. TomoTherapy ranked number one in overall
composite score, and either first or second in each contributing
category. The ratings appear in MD Buyline's Quarterly User Satisfaction
Report, which was published on July 1, 2008.
Said Fred Robertson, CEO of TomoTherapy: “We
are once again very pleased to be listed atop MD Buyline’s
quarterly rankings of radiation therapy vendors. It’s
a significant accomplishment for us, especially considering the company’s
relative youth and the next-generation
nature of the Hi·Art platform. Our
employees should be proud of their hard work. It’s
clearly making a difference.”
In rating TomoTherapy, MD Buyline wrote, “TomoTherapy
is the only vendor for the CT-based linear accelerator which delivers
radiation dose in a helical or fan beam fashion. Elekta, Siemens and
Varian offer IMRT and IGRT options on conventional linear accelerator
systems.”
MD Buyline is a market intelligence organization founded in 1983. It
provides the healthcare industry with independent analysis and reporting.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, markets and sells the TomoTherapy®
Hi·Art®
treatment system, an advanced radiation therapy system for the treatment
of a wide variety of cancers. The Hi·Art
treatment system combines integrated CT imaging with conformal radiation
therapy to deliver sophisticated radiation treatments with speed and
precision while reducing radiation exposure to surrounding healthy
tissue. The company’s stock is traded on the
NASDAQ Global Select Market under the symbol TOMO. To learn more about
TomoTherapy, please visit TomoTherapy.com.
©2008 TomoTherapy Incorporated. All rights
reserved. TomoTherapy, CTrue, the TomoTherapy logo and Hi·Art
are among trademarks, service marks or registered trademarks of
TomoTherapy Incorporated.
See the original story at: http://eon.businesswire.com/releases/2008/07/prweb1072684.htm
Post Comment:
Trackback URL: http://ca.prweb.com/pingpr.php/U3VtbS1Db3VwLUNyYXMtSGFsZi1FbXB0LVNpbmctWmVybw==
Bookmark -
Del.icio.us |
Furl |
Technorati |
Ask |
Y!MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
Share The News
Submit this press release easily to any of these major bookmarking and social media sites.